Gynecologic Oncology | Specialty

The OncLive Gynecologic Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of gynecologic cancers, including ovarian cancer, endometrial cancer, and uterine cancer, among others. This section features news articles, interviews with gynecologic oncologists in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in gynecologic cancers.

SGO Calls for Broad Changes in Managing Patient Care

May 22nd 2013

The SGO asserts that women with gynecologic cancers frequently receive uncoordinated, fragmented testing and treatment from multiple providers at a variety of sites, often without the involvement of a specialist or supportive services.

Pap Test May Detect Ovarian and Endometrial Cancers

January 10th 2013

New research has found that Papanicolaou smear tests that collect DNA in addition to providing a routine cytologic evaluation may be able to identify mutations associated with ovarian and endometrial cancers.

Dr. Dizon on PTEN Mutations in Endometrial Cancer

January 10th 2013

Don S. Dizon, MD, Assistant in Medicine, Medical Gynecologic Oncology, Massachusetts General Hospital, explains the relationship between PTEN mutations and mTOR inhibitors in endometrial cancer.

Emerging Agents for the Treatment of Ovarian Cancer

December 22nd 2012

Although the association between VEGF and ovarian cancer has been known for quite some time, researchers are still struggling to use drugs that inhibit VEGF and angiogenesis in patients with the disease.

Adjuvant Chemotherapy Improves Survival in Women With Recurrent Breast Cancer

December 6th 2012

Adjuvant chemotherapy improved survival rates in women with isolated local or regional breast cancer recurrence, according to results from the CALOR trial.

Vaccine Promotes Immune Response in Ovarian Cancer

November 19th 2012

Interim data from a phase II clinical study of the dendritic cell vaccine CVac in patients with epithelial ovarian cancer showed promising signs of improving PFS compared with the observational standard of care.

Dr. Konner on Bevacizumab in Ovarian Cancer

November 16th 2012

Jason A. Konner, MD, from Memorial Sloan-Kettering Cancer Center, explains that one of the main drivers behind research into bevacizumab in ovarian cancer is to identify which patients will benefit the most from the treatment.

Dr. Krychman on Treating Cancer-Related Sexual Issues

October 18th 2012

Michael L. Krychman, MD, Executive Director of the Southern California Center for Sexual Health and Survivorship Medicine, discusses managing and treating sexual health concerns in cancer patients and survivors.

Sentinel Lymph Node Mapping in Endometrial Cancer

October 12th 2012

Sentinel lymph node mapping shows promise in the management of endometrial cancer, especially if applied using a rigorous staging and treatment algorithm.

New Chemotherapy Strategy Emerges in Ovarian Cancer

September 24th 2012

A study evaluating first-line chemotherapy dosing strategies for treating patients with advanced epithelial ovarian cancer has delivered practice-changing findings.

Squamous Cell Carcinoma of the Anus During Pregnancy

September 10th 2012

For Tiffany Keller-Fritz, the safety of her unborn child, weighed against the urgent need to initiate treatment, required close collaboration between her oncologists and OB-GYN.

Dr. Krychman on the Awareness of Sexual Health Concerns

August 7th 2012

Dr. Michael Krychman, from he Southern California Center for Sexual Health and Survivorship Medicine, Discusses the Awareness of Sexual Health Concerns in Breast Cancer Patients.

Older Women With Early Cervical Cancer Are Less Likely to Have Surgery

August 6th 2012

Among patients with early-stage cervical cancer, women aged greater than 65 years are less likely than younger women to be treated with surgery as compared with chemoradiation.

Maintenance Erlotinib Fails to Improve Survival in Ovarian Cancer

July 31st 2012

Erlotinib given as a maintenance therapy did not improve PFS or OS in patients with epithelial ovarian cancer who had received first-line platinum-based chemotherapy.

Multidisciplinary Approaches Are Needed in Ovarian Cancer

July 23rd 2012

While ovarian cancer survival rates have improved slightly since the 1970s, the overall five-year survival for patients diagnosed with the tumor type lags behind the average rate of all cancers.

Dr. Bast Discusses Biomarkers for Ovarian Cancer

July 19th 2012

Dr. Robert Bast, from the MD Anderson Cancer Center, Discusses New Biomarker Panels for Ovarian Cancer Screening.

Heidi Donovan Discusses Prioritizing Symptoms

July 13th 2012

Heidi Donovan from the University of Pittsburgh School of Nursing Discusses Prioritizing Symptoms

Current Issues in Gynecologic Oncology: A Discussion With John Curtin, MD

July 13th 2012

Many contemporary issues in the US healthcare system affect clinicians in all areas of medicine. Some issues are even more specific to the field of gynecologic oncology.

Close Call for Cost-Effectiveness of Bevacizumab in Ovarian Cancer

July 9th 2012

Recent clinical and economic studies have suggested that ovarian cancer regimens containing bevacizumab could fall within the boundaries of cost-effectiveness, at least for some patients.

Regimen in Recurrent Endometrial Cancer Challenged: TAP Not Superior to Less-Toxic, Two-Drug Therapy

July 3rd 2012

A summary of findings from the 43rd Annual Meeting on Women's Cancer with the potential to impact routine management of women with pelvic malignancies.